Increased data output from the use of devices can accelerate trials for this therapeutic area in need of new therapies.
Victoria Hunter
Advertisement
Digital Biomarker Director, Koneksa
Articles by Victoria Hunter
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market
2
ACT Brief: Real-Time Trial Infrastructure Gaps, Built-In Data Security, and AI-Enabled CDMO Value
3
Real-Time Clinical Trials: What the FDA's Push Toward Continuous Oversight Means for Sponsors
4
Built-In, Not Bolted On: Why Clinical Data Security Has to Be a Design Principle
5